MarkJosDinubileMD

Physician

Dr. Dinubile is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

A Study to Evaluate Plasma Gelsolin in Healthy Volunteers Start of enrollment: 2023 Mar 14
Completed
Phase 1
Roles: Study Director, Contact

PubMed

6 citations
Low HDL-c levels at admission are associated with greater severity and worse clinical outcomes in patients with COVID-19 disease.
Sandra Parra, Mireia Saballs, Mark DiNubile, Mireia Feliu, Simona Iftimie
Atherosclerosis Plus. 2023-06-01
1 citations
Plasma gelsolin levels are associated with diabetes, sex, race, and poverty.
Nicole Noren Hooten, Nicolle A Mode, Edward Kowalik, Victor Omoniyi, Alan B Zonderman
Journal of Translational Medicine. 2023-03-10
8 citations
Blood-Borne Microparticles Are an Inflammatory Stimulus in Type 2 Diabetes Mellitus.
Stephen R Thom, Veena M Bhopale, Awadhesh K Arya, Deepa Ruhela, Abid R Bhat
Immunohorizons. 2023-01-01

BioAegis Therapeutics Reports Favorable Safety and Pharmacokinetic Results in Its Phase 1b/2a Dose-Escalation Study of Recombinant Human Plasma Gelsolin with Highest Doses Ever Administered to PatientsAugust 7th, 2019